Perrigo Company
PRGONYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $16.83 Prior regular-session close from the quote source.
- $16.38–$16.72 Regular-session low and high so far today.
- 1.3M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $9.23–$17.02 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own PRGO if underlying operations and margins recover, the company’s steady revenue and positive operating cash flow should justify a re-rate and equity upside.
PRGO price history
Loading recent earnings…
Investment thesis
What must happen next
Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution.StrengtheningMateriality: High
NetCashProvidedByUsedInOperatingActivities (operating_cash_flow) remained positive at $238,500,000 in FY2025. If true, investors can expect recovery via cost actions and non-cash charge normalization; if false (OCF falls), the company may need asset sales, debt restructuring, or dilutive financing.
Watch: Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
NetCashProvidedByUsedInOperatingActivities (operating_cash_flow) remained positive at $238,500,000 in FY2025.
Open source ↗Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions.HoldingMateriality: High
GrossProfit was $1,680,400,000 in FY2023, $1,542,700,000 in FY2024, and $1,494,500,000 in FY2025 — a modest decline versus the operating income swing. If gross margins hold, operating leverage and cost reductions can restore operating income; if gross_profit erodes, there is limited room to recover margins and cash flow.
Watch: A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GrossProfit was $1,680,400,000 in FY2023, $1,542,700,000 in FY2024, and $1,494,500,000 in FY2025 — a modest decline versus the operating income.
Open source ↗Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline.HoldingMateriality: Medium
Total liabilities were $5,599,700,000 as of FY2025 while operating_cash_flow was positive in FY2025 ($238,500,000). If the balance sheet remains serviceable, the company can avoid distress actions and execute restructuring to restore operating income; if not, it risks forced asset sales or dilution.
Watch: Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Total liabilities were $5,599,700,000 as of FY2025 while operating_cash_flow was positive in FY2025 ($238,500,000).
Open source ↗The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics.HoldingMateriality: Medium
OperatingIncomeLoss swung from positive ($151,900,000 in FY2023. If the loss is one-time, restoring operating income is a matter of time and execution; if the charges are recurring or reflect structural losses, the stock may need to be permanently re-rated lower.
Watch: MD&A or notes revealing that the charges are the first of recurring reserve/impairment events tied to declining product demand.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
OperatingIncomeLoss swung from positive ($151,900,000 in FY2023.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution. If true, investors can expect recovery via cost actions and non-cash charge normalization; if false (OCF falls), the company may need asset sales, debt restructuring, or dilutive financing.
Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions. If gross margins hold, operating leverage and cost reductions can restore operating income; if gross_profit erodes, there is limited room to recover margins and cash flow.
Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline. If the balance sheet remains serviceable, the company can avoid distress actions and execute restructuring to restore operating income; if not, it risks forced asset sales or dilution.
The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics. If the loss is one-time, restoring operating income is a matter of time and execution; if the charges are recurring or reflect structural losses, the stock may need to be permanently re-rated lower.
All standing thesis claims
Original report summary
underlying operations and margins recover, the company’s steady revenue and positive operating cash flow should justify a re-rate and equity upside.
Bull case and bear case
Bull case and bear case for PERRIGO Co
Where the evidence on PERRIGO Co stands: Holding on the latest evidence (Nov 7, 2026). Of its 4 thesis points, 1 strengthening and 3 holding.
Bull case: what the evidence supports
Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution.
Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions.
Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline.
The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics.
Bear case: what would count against it
Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.
A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.
Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.
Thesis-Break Engine
Thesis-break watch · PERRIGO Co
Loading the break-condition record for PERRIGO Co.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
PERRIGO Co filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
PERRIGO Co filed an SEC 8-K on 2026-10-29: Regulation FD disclosure. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
PERRIGO Co filed an SEC 8-K on 2026-08-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.
- A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.
- Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.
- MD&A or notes revealing that the charges are the first of recurring reserve/impairment events tied to declining product demand.
PRGO news
Loading headlines…
Financial statements
PRGO income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
PRGO: quick answers
- Have members of Congress traded PRGO?
- Reports made public in the last 90 days disclose 2 trades in PRGO by 1 filer: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed PRGO trade
- Which well-known investors own PRGO?
- 2 of the 37 well-known funds tracked here reported PRGO shares in their latest 13F filings. By share of the fund's portfolio: Maverick Capital, 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
PRGO in well-known investors’ portfolios
2 of 37 funds reported PRGO shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Maverick Capital | 0.04% | $4.7M | New | Q2 2026 |
| Ray DalioBridgewater Associates | 0.01% | $3.4M | +158.5% | Q2 2026 |
